Announcements and Notices - [Change in Auditors]

CANbridge Pharmaceuticals operates as a global biopharmaceutical company. The Company focuses on developing and commercialising therapeutics for treatment of orphan diseases and rare cancers. CANbridge Pharmaceuticals serves customers worldwide.

Change Of Auditor

Announcements and Notices - [Other - Business Update]

Voluntary Announcement Update On The Group'S Business Operations In The United States

Voluntary Announcement - 
Announcement Of The Grant Of Priority Review Status Of
Can103 For The Treatment Of Gaucher Disease (Gd)

Announcements and Notices - [List of Directors and their Role and Function]

List Of Directors And Their Roles And Functions

Announcements and Notices - [Change in Directors or of Important Executive Functions or Responsibilities / Change of Remuneration Committee Member]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

CANbridge Pharmaceuticals (1228 HK)

Change Of Auditor

Voluntary Announcement Update On The Group'S Business Operations In The United States

Voluntary Announcement - Announcement Of The Grant Of Priority Review Status Of Can103 For The Treatment Of Gaucher Disease (Gd)

List Of Directors And Their Roles And Functions

Appointment And Resignation Of Non-Executive Director Change In Composition Of Board Committee

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)